651. SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells.
- Author
-
Zhang, Linda, Hsu, Joanne I., Braekeleer, Etienne D., Chun-Wei Chen, Patel, Tajhal D., Martell, Alejandra G., Guzman, Anna G., Wohlan, Katharina, Waldvogel, Sarah M., Hidetaka Uryu, Tovy, Ayala, Callen, Elsa, Murdaugh, Rebecca L., Richard, Rosemary, Jansen, Sandra, Vissers, Lisenka, de Vries, Bert B. A., Nussenzweig, Andre, Shixia Huang, and Coarfa, Cristian
- Subjects
- *
DNA repair , *PHOSPHOPROTEIN phosphatases , *LEUKEMIA , *REACTIVE oxygen species , *GENE amplification , *OXIDATIVE stress - Abstract
The DNA damage response is critical for maintaining genome integrity and is commonly disrupted in the development of cancer. PPM1D (protein phosphatase Mg2+/Mn2+-dependent 1D) is a master negative regulator of the response; gain-of- function mutations and amplifications of PPM1D are found across several human cancers making it a relevant pharmacological target. Here, we used CRISPR/Cas9 screening to identify synthetic-lethal dependencies of PPM1D, uncovering superoxide dismutase-1 (SOD1) as a potential target for PPM1D-mutant cells. We revealed a dysregulated redox landscape characterized by elevated levels of reactive oxygen species and a compromised response to oxidative stress in PPM1D-mutant cells. Altogether, our results demonstrate a role for SOD1 in the survival of PPM1D-mutant leukemia cells and highlight a new potential therapeutic strategy against PPM1D-mutant cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF